Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Each of the stock options has an exercise price of $21.05 per share, the closing price of Karyopharm’s common stock on
Velcade® is a registered trademark of Takeda Pharmaceutical Company Limited
Vice President, Investor and Public Relations
857-297-2241 | firstname.lastname@example.org
Source: Karyopharm Therapeutics Inc.